Edwards Lifesciences EW Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $380.7M+317% | $91.2M-68.6% | $290.3M-12.4% | $331.5M-7.0% | $356.4M-7.3% | ||
| $40.9M-4.2% | $42.7M+8.9% | $39.2M+2.9% | $38.1M+4.1% | $36.6M-14.1% | ||
| $45.4M+15.8% | $39.2M-4.9% | $41.2M+9.9% | $37.5M-6.7% | $40.2M+26.8% | ||
| $43.8M-90.3% | $450.9M-21.4% | $573.7M+97.7% | $290.2M+3.5% | $280.4M— | ||
| $64.9M-33.4% | $97.4M+69.4% | $57.5M+16.6% | $49.3M-12.0% | $56M+12.4% | ||
| $6.3M-58.0% | $15M+900% | $1.5M-96.9% | $48.3M— | $0-100% | ||
| -$92.8M+53.2% | -$198.3M+53.6% | -$427.8M-149% | -$172.1M-302% | $85.3M— | ||
| $421.8M+939% | $40.6M-93.1% | $588.7M+10,604% | $5.5M-97.9% | $258.6M+158% | ||
| -$451.2M-3,858% | -$11.4M+98.5% | -$740.1M— | $0+100% | -$258M— | ||
| -$492M— | —— | -$595.2M-522% | $141.2M+56.9% | $90M— | ||
| -$21.1M-106% | $353.5M-31.5% | $516.2M+114% | $240.9M+7.4% | $224.4M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Edwards Lifesciences generate?
- Edwards Lifesciences (EW) generated $1.4B in operating cash flow over the trailing twelve months.
- What is Edwards Lifesciences's free cash flow?
- After $269.1M of capital expenditures, Edwards Lifesciences's free cash flow was $1.1B over the trailing twelve months, up 57.5% year over year.
- Where does Edwards Lifesciences's cash flow data come from?
- Every line is extracted from Edwards Lifesciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
